PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
December 10, 2014Current Neuropharmacology164 citationsOpen Access

Anabolic Androgenic Steroid (AAS) Related Deaths: Autoptic, Histopathological and Toxicological Findings

PFPaola FratiFBFrancesco Paolo BusardòLCLuigi Cipolloni

Structured PICO

P
Population
19 fatal cases related to Anabolic Androgenic Steroid (AAS) abuse identified from literature between 1990 and 2012
I
Intervention
Anabolic Androgenic Steroids (AAS) abuse
O
Outcome
Autoptic, histopathological and toxicological findings in AAS-related deathshard clinical

AAS abuse is associated with fatal cardiovascular events, with autopsies consistently excluding extracardiac causes of death in reported fatal cases.

Abstract

Anabolic androgenic steroids (AASs) represent a large group of synthetic derivatives of testosterone, produced to maximize anabolic effects and minimize the androgenic ones. AAS can be administered orally, parenterally by intramuscular injection and transdermally. Androgens act by binding to the nuclear androgen receptor (AR) in the cytoplasm and then translocate into the nucleus. This binding results in sequential conformational changes of the receptor affecting the interaction between receptor and protein, and receptor and DNA. Skeletal muscle can be considered as the main target tissue for the anabolic effects of AAS, which are mediated by ARs which after exposure to AASs are up-regulated and their number increases with body building. Therefore, AASs determine an increase in muscle size as a consequence of a dose-dependent hypertrophy resulting in an increase of the cross-sectional areas of both type I and type II muscle fibers and myonuclear domains. Moreover, it has been reported that AASs can increase tolerance to exercise by making the muscles more capable to overload therefore shielding them from muscle fiber damage and improving the level of protein synthesis during recovery. Despite some therapeutic use of AASs, there is also wide abuse among athletes especially bodybuilders in order to improve their performances and to increase muscle growth and lean body mass, taking into account the significant anabolic effects of these drugs. The prolonged misuse and abuse of AASs can determine several adverse effects, some of which may be even fatal especially on the cardiovascular system because they may increase the risk of sudden cardiac death (SCD), myocardial infarction, altered serum lipoproteins, and cardiac hypertrophy. The aim of this review is to focus on deaths related to AAS abuse, trying to evaluate the autoptic, histopathological and toxicological findings in order to investigate the pathophysiological mechanism that underlines this type of death, which is still obscure in several aspects. The review of the literature allowed us to identify 19 fatal cases between 1990 and 2012, in which the autopsy excluded in all cases, extracardiac causes of death.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Frati et al. (2014) studied this question.

synapsesocial.com/papers/6a7659bcaecdb601a7475223https://doi.org/10.2174/1570159x13666141210225414
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Sudden Cardiac Death During Exercise in a Weight Lifter Using Anabolic Androgenic Steroids: Pathological and Toxicological Findings1990 · 129 citations
  2. 2The Athlete’s Heart2000 · 1,105 citations
  3. 3Swim Training Improves Myocardial Resistance to Ischemia in Rats2000 · 14 citations
  4. 4Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification.1992 · 689 citations
  5. 5Sex hormones and aortic wall remodeling in an arteriovenous fistula2007 · 14 citations